Mizuho


Mizuho Weighs in on Endo International plc – Ordinary Shares (ENDP) Following Analyst Event

Endo International plc – Ordinary Shares (NASDAQ:ENDP) recently held an analyst event where management hosted a sell-side meeting at its Par facility, which …

Analysts Chime in on Healthcare Giants Valeant Pharmaceuticals Intl Inc (VRX) And Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

Healthcare analysts weigh in on two healthcare giants Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). While one analyst sees Valeant taking …

Analysts Chime in on Two Rising Healthcare Stocks: Bioline RX Ltd (BLRX), Endo International plc – Ordinary Shares (ENDP)

Healthcare analysts chimed in on Bioline RX Ltd (NASDAQ:BLRX) and Endo International plc – Ordinary Shares (NASDAQ:ENDP), as both stocks are among the top performers today. The …

Analysts Mixed on Two Biotech Giants: Valeant Pharmaceuticals Intl Inc (VRX) and Allergan plc Ordinary Shares (AGN)

Amid big changes underway for Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and an acquisition that has some investors raising an eyebrow at Allergan plc Ordinary Shares …

This Top Analyst Sees Several Reasons to Like Endo International plc – Ordinary Shares (ENDP)

Mizuho top analyst Irina Koffler assesses both short-term and long-term for Endo International plc – Ordinary Shares (NASDAQ:ENDP), believing there is every reason …

Mizuho Top Analyst Weighs in on Allergan plc Ordinary Shares (AGN) Amid Vitae Pharmaceuticals Inc (VTAE) Acquisition

Allergan plc Ordinary Shares (NYSE:AGN) announced today that it had entered an agreement to acquire Vitae Pharmaceuticals Inc (NASDAQ:VTAE), a clinical-stage biotech company, …

Mizuho Securities Bullish on Tiffany & Co. (TIF)

Mizuho Securities analyst Betty Chen reiterates a Buy rating for Tiffany & Co. (NYSE:TIF) and maintains a price target of $72.

Here’s Why Mizuho Top Analyst Upgraded Endo International plc – Ordinary Shares (ENDP)

Endo International plc – Ordinary Shares (NASDAQ:ENDP) just released strong second-quarter results, posting revenue of $920.9 million and EPS of $0.

Is Philidor Valeant Pharmaceuticals Intl Inc’s Achilles’ Heel?

Drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) faces a barrage of scrutiny, from the U.S.

Mizuho Analyst Reiterates Neutral Rating on Pandora Media Inc (P)

Mizuho analyst, Neil Doshi, reiterates a Neutral rating on Pandora Media Inc (NYSE:P) with an $11.00 price target.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts